Search results for “2-Azetidinone” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 922 patents, we discovered top 119 key players by total patent application. E. R. Squibb & Sons LLC, AstraZeneca Pharmaceutical Co., Ltd., Schering Corp. are dominant in this area. They take 28.52% of the total patent filing.
E. R. Squibb & Sons LLC
New Jersey, United States
Patent: 125
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 85
Schering Corp.
New Jersey, United States
Patent: 53
Takeda Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 40
Fujisawa Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 40
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 39
The Upjohn Co.
Michigan, United States
Patent: 32
Merck & Co., Inc.
New Jersey, United States
Patent: 28
Yamanouchi Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 24
Pfizer Inc.
New York, United States
Patent: 22
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 5 patents applied in the last 5 years. We discover 6 most active companies in this area. The fast-growing Zhejiang Hisoar Chuannan Pharmaceutical Co. Ltd., University of Notre Dame, Jiangxi Fushine Pharmaceutical Co., Ltd. take 60.00% of patent filing during this period.
Zhejiang Hisoar Chuannan Pharmaceutical Co. Ltd.
Zhejiang Sheng, China
Patent: 1
University of Notre Dame
Indiana, United States
Patent: 1
Jiangxi Fushine Pharmaceutical Co., Ltd.
Jiangxi Sheng, China
Patent: 1
Fujian Zishanyuan Biology Co. Ltd.
Fujian Sheng, China
Patent: 1
Chongqing Rui Bolai Pharmaceutical Co., Ltd.
Chongqing Shi, China
Patent: 1
Zhejiang Hisoar Pharmaceutical Co., Ltd.
Zhejiang Sheng, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 5 patents in last 5 years, we discover 4 new entrants. Jiangxi Fushine Pharmaceutical Co., Ltd., Fujian Zishanyuan Biology Co. Ltd., Chongqing Rui Bolai Pharmaceutical Co., Ltd. are the most active new entrants in this area.
Jiangxi Fushine Pharmaceutical Co., Ltd.
Jiangxi Sheng, China
Patent: 1
Fujian Zishanyuan Biology Co. Ltd.
Fujian Sheng, China
Patent: 1
Chongqing Rui Bolai Pharmaceutical Co., Ltd.
Chongqing Shi, China
Patent: 1
Zhejiang Hisoar Pharmaceutical Co., Ltd.
Zhejiang Sheng, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 56 patents, we discovered top 17 universities and scientific research institutions by total patent application. University of Notre Dame, Georgetown University School of Medicine, President & Fellows of Harvard College are dominant in this area. They take 51.79% of the total patent filing.
University of Notre Dame
Indiana, United States
Patent: 11
Georgetown University School of Medicine
District of Columbia, United States
Patent: 7
President & Fellows of Harvard College
Massachusetts, United States
Patent: 2
Chongqing University
Chongqing Shi, China
Patent: 2
University of California
California, United States
Patent: 1
Council of Scientific & Industrial Research
Delhi, India
Patent: 1
Pontificia Universidad Católica de Chile
Chile
Patent: 1
Beijing University of Chemical Technology
Beijing Shi, China
Patent: 1
University of Milan
Lombardia, Italy
Patent: 1
Shanghai Institute of Pharmaceutical Industry
Shanghai Shi, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: